Agilent Technologies, Inc.
Close on Nov 20, 2026Market cap $48.04BP/E 33.6Yield 0.58%
Agilent Technologies FDA MAUDE Adverse Event Reports by Quarter
FDA MAUDE Adverse Event Reports — U.S. Medical Device Industry Total (reports)
Agilent Technologies FDA MAUDE Adverse Event Reports: 963,661 in Q3 FY26, up 29.6% from a year earlier. That is the highest of the 43 quarters on record here.
Where the Q3 FY26 figure comes from
Source: U.S. FDA MAUDE Adverse Event Reports Database (openFDA API — U.S. Medical Device Industry Total) ↗
Reported in U.S. Food & Drug Administration (openFDA API).
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Agilent Technologies FDA MAUDE Adverse Event Reports, quarterly Q1 FY16–Q3 FY26 [Data set]. Compiled from Agilent Technologies SEC filings and investor materials. https://stockdatahq.com/stocks/a/kpis/fda-maude-industry
See every metric in the Agilent Technologies KPI table. Data updated Nov 8, 2026.
See a number that looks wrong?